Presentations

Oct, 2014 – Envisage LLC – founded in 2014 to identify, create and advanced broad spectrum, immunology drug targets. To view our 2014 presentation click here: Envisage LLC – Pharma_non_confidential_October 2014

 

March, 2015 – Envisage LLC selects targets of interest. To view our 2015 presentation click here: Mar 22 2015_Envisage LLC – Organic-Immuno Asset Presentation_Confidential_March 2015.

Press Releases

News ArticleDate
Screen Therapeutics Announces Preliminary Findings on Targeting LAIR-1 and Other ECM ProteinsMarch 01, 2022
Screen Therapeutics enters into an immuno-oncology drug development partnership with ImmunaccelDecember 05, 2019
ENVISAGE and the Wistar Institute forge new venture and value creation partnershipMarch 10, 2015

March 1, 2022 –  Screen Therapeutics Announces Preliminary Findings on Targeting LAIR-1 and Other ECM Proteins

December, 2019 – Screen Therapeutics enters into an immuno-oncology drug development partnership with Immunaccel

March, 2015 –  ENVISAGE and the Wistar Institute forge new venture and value creation partnership